コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e nature of the counter cation in the oocyte bath solution.
2 in the absence and presence of Cd(2+) in the bath solution.
3 was prevented when NFPS was included in the bath solution.
4 x is formed when fluo-3 meets calcium in the bath solution.
5 din (25--75 microg ml(-1)) in HCO(3)(-)-free bath solution.
6 xchange system in equilibrium with a uniform bath solution.
7 s were obtained when tetrodotoxin was in the bath solution.
8 ibited by addition of 10 microM Oxo-M to the bath solution.
9 ited KATP channel activity when added to the bath solution.
10 or GTP and ATP (1 mmol/L) were added to the bath solution.
11 d either through the patch pipette or in the bath solution.
12 ng pipette and with metabolic poisons in the bath solution.
13 .5 mM EGTA) or addition of 10 mM Co2+ to the bath solution.
14 s were perfused with identical perfusate and bath solutions.
15 the response to changes in osmolality of the bathing solution.
16 hed by removing Na(+) from the extracellular bathing solution.
17 EG) or by lowering the ionic strength in the bathing solution.
18 ted by adding and removing mannitol from the bathing solution.
19 polyanionic dextran sulfate to the membrane bathing solution.
20 when cells were perfused with a Ca(2+)-free bathing solution.
21 +) with BAPTA or by omitting Ca(2+) from the bathing solution.
22 ed when cells were incubated in a hypertonic bathing solution.
23 vitro application of losartan to the serosal bathing solution.
24 by adding mannitol (50 or 100 mmol/l) to the bathing solution.
25 igh [Ca2+]i induced by empirically optimized bathing solutions.
26 in the presence of calyculin A (1 microM in bath solution), a membrane permeant inhibitor of phospha
27 enhanced the sensitivity of isolated TRCs to bath solution acidification due to activation of the PA
28 ed significantly in CaM-enriched (20 microM) bath solution and this effect was prevented by a specifi
30 icantly increased calcium currents in normal bathing solutions and during exposure to 110 mM BaCl(2)
31 (ASIC) blocker amiloride, absent in Na+-free bathing solution, and enhanced by either Ca2+-free buffe
33 tes were deformed with pneumatic ejection of bath solution at 5-15 psi using a glass pipette (7-15 mi
34 r of voltage-dependent Ca2+ channels, to the bath solution blocked the stimulatory effects of glutama
35 y activating current was reduced in Na+-free bathing solution but enhanced when the extracellular K+
36 (2+) exchanger (NCX) via alkalization of the bath solution, by adding lanthanum, or by substitution o
37 annel-impermeable N-methyl-D-glucamine-based bath solutions, consistent with increases in the Na(+) t
42 saicin or 1.6 microm resiniferatoxin using a bathing solution containing 10 microm Ruthenium Red (to
43 f 50 nM antiPGE2 antibody to the basolateral bathing solution decreased basal Isc by 20 % and shifted
44 io)triphosphate (100 mum) to the cytoplasmic bathing solutions decreased the activity of the ORCC and
45 r PEG, addition of the crown to the membrane-bathing solution decreases the ionic conductance of the
46 pipette solution, addition of steroid to the bath solution dramatically shifted the steroid potentiat
48 at pungent chemicals added to the pipette or bath solution easily activated TRPA1 in cell-attached pa
49 moval of CO(2)/HCO(3)(-) from the blood-side bathing solution elicited a approximately 50% reduction
50 was omitted or substituted for Sr(2+) in the bath solution, if neurons were treated with carbonylcyan
55 f nanomolar concentrations of peptide in the bathing solution induced a transmembrane conductance tha
56 uced by negative osmotic pressure (hypotonic bath solutions) induced a large outwardly rectifying Cl-
57 h Mg(2+) and Co(3+)Hex concentrations in the bath solution, it is observed that the spacing is largel
58 c mGluR5 antagonist, MPEP was applied in the bath solution, LTP was enhanced in layer VI, and blocked
59 specific mGluR1 antagonist, LY367385, to the bath solution, LTP was reduced in layer II/III and layer
63 and generated by removal of Mg(2+) from the bathing solution or by raising extracellular K(+) from 3
64 nd after either changes in osmolarity of the bathing solutions or the additions of amphotericin B, ep
65 ) instead of Ca(2+), (iii) using Ca(2+)-free bath solution, or (iv) buffering [Ca(2+)](i) with BAPTA-
66 rrent was reduced by removing Na(+) from the bath solution, or by knocking down levels of Slack using
70 presence of a NMDA antagonist, D-AP5, in the bath solution, potentiation was blocked in layer II/III,
72 (S)-3,5-dihydroxyphenylglycine (DHPG) to the bathing solution, pyramidal cells initially firing regul
73 microM diC8-PIP(2) in the patch pipette and bathing solutions, respectively, inhibited angiotensin I
74 -5 micro M of either of them to the membrane bathing solutions resulted in formation of long-lived an
77 s not restored by adding excess BAPTA to the bathing solution, so as to reverse the Ca2+ gradient.
78 presence of isosmolar luminal perfusate and bath solutions, spontaneous fluid absorption rates (nl/m
80 d by hyposmotic (250 osmol (l solution)(-1)) bath solution stimulated Gd(3+)-sensitive ICat in smooth
81 2P channels are more profound in Na(+)-based bath solutions than in channel-impermeable N-methyl-D-gl
87 After a period of baseline measurements, the bathing solution was changed either to one of identical
90 MM) in the range 20-511 kDa, added to the TM bathing solution was used to exert an osmotic pressure.
91 ver that amplifies currents in divalent-free bath solutions, we show that EC CRAC has similar charact
95 ut patches was increased by perfusion of the bath solution with 30 microm PIP(2) plus 100 microm GTP
97 ently reduced ICl,vol in Ca2+-free hypotonic bath solutions with strong intracellular Ca2+ (Ca2+i) bu
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。